FUS and prostate cancer: This TF is well known for its role in oncogenic gene fusion products in multiple cancers including prostate cancer (TMPSSR2-ERG and NDRG1-ERG), in Ewing’s sarcoma (EWS-ERG) and acute myeloid leukemia (FUS-ERG) [34].